Mats Wahlstrom, Director at Coherus BioSciences, Inc. (CHRS), sold 8,028 shares at $33.91 ($272K) on 2015-08-17, disclosed to the SEC on 2015-08-19.
Open-market sale of $272k CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TLSI | BUY | 2024-11-25 | $23K | — | Filing → |
| TLSI | BUY | 2024-11-22 | $47K | — | Filing → |
| CHRS | SELL | 2020-06-19 | $6.9M | — | Filing → |